TCRR
TCR2 Therapeutics Inc. Common Stock
TCRR
TCRR
Delisted
TCRR was delisted on the 31st of May, 2023.
82 hedge funds and large institutions have $544M invested in TCR2 Therapeutics Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 36 increasing their positions, 12 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
52% less call options, than puts
Call options by funds: $708K | Put options by funds: $1.47M
Holders
82
Holding in Top 10
2
Calls
$708K
Puts
$1.47M
Top Buyers
| 1 | +$40.5M | |
| 2 | +$30.7M | |
| 3 | +$24.4M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$20.9M |
| 5 |
BlackRock
New York
|
+$20.6M |
Top Sellers
| 1 | -$2.76M | |
| 2 | -$2.73M | |
| 3 | -$1.02M | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$709K |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$591K |